The Modi government’s reforms have tinkered with FDI norms twice, first in November 2015 and more recently in June this…
It is human nature to perceive change as a threat. But turning this threat into an opportunity is a crucial…
Concerned with declining pharma exports in the recent past, the Ministry of Commerce & Industry has tried to burnish the…
A notice dated March 30 from the Drug Controller General (India) asking for ‘science-based suggestions/ comments’ on the pros and…
Manufacturing quality has now become probably the single most important concern in the boardrooms of pharmaceutical companies in India
The fixed dose combination (FDC) issue has been a contentious one for years and on March 10 came back to…
In his third budget, Finance Minister Arun Jaitley has taken one more shot at a balancing act between maintaining fiscal…
As we mark yet another Women’s Day this March, here are some sobering words from Sanghita Bhattacharyya, Senior Public Health…
Precious things come in small packages (think diamonds)
All eyes are once again on India’s Finance Minister Arun Jaitley as he prepares to present the Modi Government’s second…
I’d hazard a guess that there is hardly anyone who is not a user of e-commerce platforms to ease the…
A new year brings with it new hope but all indications are that 2016 is going to be a mixed…
Could New Jersey Superior Court’s decision this October be a wake up call for Indian companies with global ambitions
If the latest edition of the Antal Global Snapshot (AGS) on annual global hiring and firing trends is any indicator,…
In our last issue, we highlighted Swati Spentose’s quiet rise to become a Rs 40-crore speciality API manufacturer
Vishal Jajodia could sign up as a poster boy for Prime Minister Narendra Modi’s Make In India campaign
Besides the balanced reasoning within the Delhi HC judgement, it is the SC’s intervention which could see this case go…
The last month saw a major milestone in the patent versus patient debate